In This Section      
Print This Page

News and Stories

Latest News


2018 Young Investigators Day: Call for Abstracts
This year, the abstracts will be accepted between now and January 24, 2018.  Each submission should include: a Call for Abstract Cover Sheet, applicant’s CV, abstract, essay of not more than 250 words, and a letter of recommendation. Submissions must be emailed to

blue cells

Noninvasive Ultrasound Pulses Used to Precisely Tweak Rat Brain Activity
Researchers developed a noninvasive way to release and deliver concentrated amounts of a drug to the brain of rats in a temporary, localized manner using ultrasound. Because these new method can be applied to many other drugs, this new method has the potential to advance many therapies and studies inside and outside the brain.


Some Cells Need a ‘Haircut’ Before Duplicating
Researchers say this finding is key to better understanding how cells decide to undergo mitosis, the maintenance of tissues and the formation of cancer. They also hope their work will shed light on cilia-related diseases, like polycystic kidney disease, and certain forms of intellectual disability.

fever chart

Here’s Why You Don’t Feel Jet-Lagged When You Run a Fever
A clump of just a few thousand brain cells, no bigger than a mustard seed, controls the daily ebb and flow of most bodily processes in mammals — sleep/wake cycles, most notably. Now, scientists report direct evidence in mice for how those cell clusters control sleep and relay light cues about night and day throughout the body.


Dual Strategy Teaches Mouse Immune Cells to Overcome Cancer’s Evasive Techniques
By combining two treatment strategies, researchers report they lengthened the lives of mice with skin cancer more than by using either strategy on its own. The combination technique is easily tailored to different types of cancer and have the potential to enhance treatment options for a wide variety of cancer patients.


Search On For Drug to Tame ‘Hyperactive’ Zinc Transporter and Lower Type 2 Diabetes Risk
Study suggests that a common variant that increases type 2 diabetes risk makes a protein that is more efficient than its less risky counterpart. The “hyperactive” variant, has clarified a long-standing question about the workings of the protein the gene makes. The results may help in identifying drugs that would slow the protein down and perhaps lower diabetes risk for millions.

News By Topic

Tissue culture

Addiction (back to top)

Aging (back to top)

Anatomy and Evolution (back to top)

Autism (back to top)

Cancer: Potential treatments (back to top)

Cancer: Metastasis and cell migration (back to top)

Cancer: Learning more about the disease (back to top)

Cardiovascular Disease (back to top)

Cystic Fibrosis (back to top)

Diabetes and Obesity (back to top)

Education: Graduate and medical (back to top)

Employment (back to top)

Epigenetics: Inheritance beyond the genome (back to top)

Funding Education (back to top)

Funding Scientific Discovery (back to top)

Genes, Genomics and Bioinformatics (back to top)

Genetic Disorders (back to top)

Hearing and Deafness (back to top)

HIV (back to top)

Immune System (back to top)

Learning and Memory (back to top)

Liver Disease (back to top)

Model Organisms (back to top)

Molecular Biology (back to top)

Muscle Wasting Diseases (back to top)

Nanotechnology (back to top)

Treating Neurological Diseases (back to top)

Pain (back to top)

Parasitic Diseases (back to top)

Proteomics (back to top)

Research Integrity (back to top)

Smell and Taste (back to top)

Stem Cells (back to top)

Synthetic Biology (back to top)

Telomeres and Telomerase (back to top)

Technology (back to top)

Touch and Skin Diseases (back to top)

Translating Basic Research: From bench to bedside (back to top)

Vision and Blindness (back to top)